Omega Healthcare director awarded 3,778 shares

Omega Healthcare Investors director Burke W. Whitman received an equity grant of 3,778 shares of common stock as director compensation.

Rhea-AI Filing Summary

Omega Healthcare Investors director Burke W. Whitman received an equity grant of 3,778 shares of common stock as director compensation. The award was valued at $43.67 per share on the grant date of June 5, 2026 and was made under a Restricted Stock Grant Award Agreement.

The shares will vest on the date of the company’s 2027 Annual Meeting of Shareholders, about one year after the grant, and will then convert to common stock on a one-for-one basis. After this award, Whitman directly holds a total of 47,931 common shares.

Insider Trade Summary

Grant/Award: 3,778 shares

Grant/Award 1 txn

Insider WHITMAN BURKE W

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,778	$43.67	$165K

Holdings After Transaction: Common Stock — 47,931 shares (Direct)

Footnotes (1)

1. F1. Represents Director compensation granted on June 5, 2026 via a Restricted Stock Grant Award Agreement which will vest on the date of the Company's 2027 Annual Meeting of Shareholders, which is approximately one (1) year from the date of the grant and will convert to common stock on a one-for-one basis.

Key Figures

Director stock grant: 3,778 shares Grant reference price: $43.67 per share Total holdings after grant: 47,931 shares +1 more

4 metrics

Director stock grant 3,778 shares Restricted stock compensation granted June 5, 2026

Grant reference price $43.67 per share Value used for the June 5, 2026 award

Total holdings after grant 47,931 shares Common stock directly held after the transaction

Vesting timeline Approximately 1 year From June 5, 2026 grant to 2027 Annual Meeting vesting

Key Terms

Restricted Stock Grant Award Agreement, Director compensation, Annual Meeting of Shareholders, common stock

4 terms

Restricted Stock Grant Award Agreement financial

"Represents Director compensation granted on June 5, 2026 via a Restricted Stock Grant Award Agreement"

Director compensation financial

"Represents Director compensation granted on June 5, 2026 via a Restricted Stock Grant Award Agreement"

Annual Meeting of Shareholders financial

"will vest on the date of the Company's 2027 Annual Meeting of Shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

common stock financial

"will convert to common stock on a one-for-one basis"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did OHI director Burke W. Whitman report?

Burke W. Whitman reported receiving 3,778 shares of Omega Healthcare Investors common stock as director compensation. The grant was made on June 5, 2026 under a Restricted Stock Grant Award Agreement, rather than through an open-market purchase.

At what price was the June 2026 OHI director stock award valued?

The 3,778-share award to director Burke W. Whitman was valued at $43.67 per share on the June 5, 2026 grant date. This price reflects the reference value used for the restricted stock compensation grant.

When will Burke W. Whitman’s June 2026 OHI stock grant vest?

The director’s restricted stock grant will vest on the date of Omega Healthcare Investors’ 2027 Annual Meeting of Shareholders. That meeting is approximately one year from the June 5, 2026 grant date, after which the award converts into common stock.

How many OHI shares does Burke W. Whitman hold after this grant?

Following the June 5, 2026 restricted stock award, Burke W. Whitman directly holds 47,931 shares of Omega Healthcare Investors common stock. This total includes the 3,778-share director compensation grant reported in the Form 4 filing.

Is the June 2026 OHI Form 4 a stock purchase or a compensation grant?

The Form 4 reflects a compensation grant, not an open-market stock purchase. Director Burke W. Whitman received 3,778 restricted shares as director compensation, which will vest at the 2027 Annual Meeting and then convert into common stock one-for-one.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/09/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WHITMAN BURKE W

(Last) (First) (Middle)

303 INTERNATIONAL CIRCLE

SUITE 200

(Street)

HUNT VALLEY MARYLAND 21030

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OMEGA HEALTHCARE INVESTORS INC [ OHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		A		3,778(1)	A	$43.67	47,931	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents Director compensation granted on June 5, 2026 via a Restricted Stock Grant Award Agreement which will vest on the date of the Company's 2027 Annual Meeting of Shareholders, which is approximately one (1) year from the date of the grant and will convert to common stock on a one-for-one basis.

	/s/ Meghan C. Lyons, Attorney-in-Fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)